MARKET

AFMD

AFMD

Affimed
NASDAQ
6.05
-0.69
-10.24%
Closed 19:36 06/18 EDT
OPEN
6.70
PREV CLOSE
6.74
HIGH
6.75
LOW
6.02
VOLUME
226.13K
TURNOVER
0
52 WEEK HIGH
8.95
52 WEEK LOW
2.235
MARKET CAP
92.13M
P/E (TTM)
-0.9017
1D
5D
1M
3M
1Y
5Y
Affimed (AFMD) Gets a Buy from Truist Financial
TipRanks · 2d ago
Weekly Report: what happened at AFMD last week (0610-0614)?
Weekly Report · 3d ago
Analysts Offer Insights on Healthcare Companies: R1 RCM (RCM), Affimed (AFMD) and Nurix Therapeutics (NRIX)
TipRanks · 3d ago
Affimed Is Maintained at Buy by Laidlaw & Co.
Dow Jones · 06/13 14:34
Affimed Price Target Raised to $25.00/Share From $15.00 by Laidlaw & Co.
Dow Jones · 06/13 14:34
Laidlaw & Co. Maintains Buy on Affimed, Raises Price Target to $25
Benzinga · 06/13 14:23
Affimed (AFMD) Receives a Buy from Truist Financial
TipRanks · 06/13 11:18
Affimed Price Target Maintained With a $10.00/Share by HC Wainwright & Co.
Dow Jones · 06/13 10:27
More
About AFMD
Affimed N.V. is a clinical-stage biopharmaceutical company focused on discovering and developing cancer immunotherapies. The Company's product candidates are developed in the field of immuno-oncology, which represents an approach to cancer research that seeks to harness the body's own immune system to fight tumor cells. Its pipeline includes AFM13, AFM13 + adoptive NK cells, AFM13 + anti-PD-1, AMF24, AMF26, AMF28 and AMF32. The Company is enrolling patients into a registration-directed study of AFM13 for CD30-positive relapsed/refractory peripheral T-cell Lymphoma and into a Phase 1/2a dose escalation/expansion study of AFM24 for the treatment of advanced EGFR-expressing solid tumors. Its preclinical product candidates include AMF26 for treating multiple myeloma, as well as AMF28 and AMF32, for treating of multiple tumor targets. In addition, the Company collaborates with Genentech to develop and commercialize certain product candidates for treating multiple cancers.

Webull offers Affimed NV stock information, including NASDAQ: AFMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AFMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AFMD stock methods without spending real money on the virtual paper trading platform.